We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Immune Response Following Surgical Management of Renal Tumors

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00289146
First Posted: February 9, 2006
Last Update Posted: September 24, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Kenneth Ogan, MD, Emory University
  Purpose
Examine the effects of renal surgery on the immune system.

Condition
Kidney Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Comparison of Immune Response Following Surgical Management of Renal Tumors

Resource links provided by NLM:


Further study details as provided by Kenneth Ogan, MD, Emory University:

Biospecimen Retention:   Samples Without DNA
Blood samples

Estimated Enrollment: 50
Study Start Date: November 2005
Study Completion Date: August 2006
Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
Detailed Description:
Prospective study examining the effects of different surgical procedures on immune function. This may have bearing on overall cancer specific recurrence and survival.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients undergoing open or laparoscopic surgeries for the treatment of kidney tumors.
Criteria

Inclusion Criteria:

  • Kidney tumor patients scheduled for open or laparoscopic surgery

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00289146


Locations
United States, Georgia
Emory University
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Emory University
Investigators
Principal Investigator: Kenneth Ogan, MD Emory University
  More Information

Responsible Party: Kenneth Ogan, MD, Associate Professor, Emory University
ClinicalTrials.gov Identifier: NCT00289146     History of Changes
Other Study ID Numbers: 0021-2005
First Submitted: February 7, 2006
First Posted: February 9, 2006
Last Update Posted: September 24, 2013
Last Verified: September 2013

Keywords provided by Kenneth Ogan, MD, Emory University:
kidney cancer, immunology

Additional relevant MeSH terms:
Kidney Neoplasms
Carcinoma, Renal Cell
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Kidney Diseases
Urologic Diseases
Adenocarcinoma
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type